Bites - Management of Infection Guidance for Primary Care |
| Publication: 30/09/2010 |
| Next review: 11/03/2023 |
| Clinical Guideline |
| UNDER REVIEW |
| ID: 2259 |
| Approved By: |
| Copyright© Leeds Teaching Hospitals NHS Trust 2022 |
This Clinical Guideline is intended for use by healthcare professionals within Leeds unless otherwise stated. |
The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee has recommended restricting the use of fluoroquinolone antibiotics following a review of disabling and potentially long-lasting side effects mainly involving muscles, tendons, bones and the nervous system. This includes a recommendation not to use them for mild or moderately severe infections unless other antibiotics cannot be used (MHRA advice November 2018).
Bites - human and animal
The previous version of this guideline is being reviewed. In the meantime, please refer to NICE guidance :
Human and animal bites: antimicrobial prescribing NG 184
visual-summary-pdf-8897023117 (nice.org.uk)
Overview | Human and animal bites: antimicrobial prescribing | Guidance | NICE
| |
Provenance
| Record: | 2259 |
| Objective: | |
| Clinical condition: | Bites |
| Target patient group: | |
| Target professional group(s): | Primary Care Doctors Pharmacists |
| Adapted from: |
Evidence base
Document history
LHP version 1.0
Related information
Not supplied